4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) IPO

4D Molecular Therapeutics, Inc.

IPO

Priced at US$23.00 a share on Dec 10, 2020.

Price
US$23.00 a share
Shares offered
8,400,000 shares of common stock
Offering size
US$193.2 million
Underwriters' option
Up to 1,260,000 more shares
Underwriters
Goldman Sachs & Co. LLC, BofA Securities, Evercore ISI · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceOct 14, 2020
Filed publiclyNov 17, 2020
Amended twiceNewest Dec 10, 2020
Shares registered with an exchangeDec 8, 2020
Declared effective by the SECDec 10, 2020
Final prospectus, with the priceDec 14, 2020

From the cover of the final prospectus (424B4) filed Dec 14, 2020